Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Yili Pharmaceutical Technology is a China-based pharmaceutical company specializing in the research, development, and production of chemical raw materials and pharmaceutical intermediates. The company provides a range of services including custom synthesis, process optimization, and contract manufacturing (CMO/CDMO) for the global life sciences industry. Their product portfolio primarily focuses on high-quality small molecule compounds used in various therapeutic applications. With a strong emphasis on quality control and technical innovation, they support drug development from laboratory scale to commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Yili Pharmaceutical Technology.